Immuron Ltd.
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Public
- Established
- 1994-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.immuron.com
Clinical Trials
4
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (75.0%)Phase 1
1 (25.0%)Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model
Phase 2
Active, not recruiting
- Conditions
- DiarrheaInfectious DiarrheaTravelers Diarrhea
- Interventions
- Other: Placebo
- First Posted Date
- 2023-07-06
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Immuron Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05933525
- Locations
- 🇺🇸
Pharmaron Clinical Pharmacology Center, Baltimore, Maryland, United States
Treatment for Clostridium-difficile Infection With IMM529
Phase 1
Terminated
- Conditions
- Clostridium Difficile Infection RecurrenceClostridium Difficile Infection
- First Posted Date
- 2017-02-27
- Last Posted Date
- 2019-12-26
- Lead Sponsor
- Immuron Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT03065374
- Locations
- 🇮🇱
Hadassah Medical Center, Jerusalem, Israel
🇮🇱Sheba Hospital, Tel HaShomer, Israel
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Phase 2
Completed
- Conditions
- Non-alcoholic Steatohepatitis (NASH)
- First Posted Date
- 2014-12-15
- Last Posted Date
- 2020-02-21
- Lead Sponsor
- Immuron Ltd.
- Target Recruit Count
- 133
- Registration Number
- NCT02316717
- Locations
- 🇺🇸
eStudySite, Chula Vista, California, United States
🇺🇸University of California San Diego, San Diego, California, United States
🇺🇸Quest Clinical Research, San Francisco, California, United States
Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis
Phase 2
Withdrawn
- Conditions
- Nonalcoholic Steatohepatitis
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2012-12-06
- Lead Sponsor
- Immuron Ltd.
- Registration Number
- NCT01466894
News
No news found